
Shares of AstraZeneca Plc, the UK’s biggest drugmaker, will start trading on the New York Stock Exchange on Monday following a listing upgrade to replace its American Depositary Receipts that were on Nasdaq.


Shares of AstraZeneca Plc, the UK’s biggest drugmaker, will start trading on the New York Stock Exchange on Monday following a listing upgrade to replace its American Depositary Receipts that were on Nasdaq.

Leave A Comment